Urgency: Promise or Problem for FDA-Regulated Companies

A couple of months ago I was engaged in a brief, friendly dialogue with one of my close friends – a college buddy – about a current business imperative:   urgency.      My friend is a Senior Partner with a large, very well-known business consulting firm, and has responsibility for major projects within large pharmaceutical companies. As part of our regular communications, my friend...
read more